Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.

Hsu CC, Chang HY, Huang MC, Hwang SJ, Yang YC, Lee YS, Shin SJ, Tai TY.

Diabetologia. 2012 Dec;55(12):3163-72. doi: 10.1007/s00125-012-2700-4. Epub 2012 Aug 26.

PMID:
22923064
2.

HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.

Sugawara A, Kawai K, Motohashi S, Saito K, Kodama S, Yachi Y, Hirasawa R, Shimano H, Yamazaki K, Sone H.

Diabetologia. 2012 Aug;55(8):2128-31. doi: 10.1007/s00125-012-2572-7. Epub 2012 May 12. Erratum in: Diabetologia. 2013 Nov;56(11):2548.

PMID:
22580991
3.

Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes.

Rodríguez-Segade S, Rodríguez J, García López JM, Casanueva FF, Camiña F.

Diabet Med. 2012 Dec;29(12):1562-6. doi: 10.1111/j.1464-5491.2012.03767.x.

PMID:
22913483
4.

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.

PMID:
17331857
5.

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P; Casale Monferrato Study.

Diabetes Care. 2003 Jul;26(7):2150-5.

PMID:
12832328
6.

Relation of microalbuminuria to glycosylated hemoglobin and duration of type 2 diabetes.

Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, Ray D.

Niger J Clin Pract. 2013 Apr-Jun;16(2):216-20. doi: 10.4103/1119-3077.110159.

7.
8.

The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.

Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjörnsdottir S.

Diabetologia. 2012 Nov;55(11):2946-53. doi: 10.1007/s00125-012-2681-3. Epub 2012 Aug 16.

PMID:
22895807
9.

Association between insulin resistance and development of microalbuminuria in type 2 diabetes: a prospective cohort study.

Hsu CC, Chang HY, Huang MC, Hwang SJ, Yang YC, Tai TY, Yang HJ, Chang CT, Chang CJ, Li YS, Shin SJ, Kuo KN.

Diabetes Care. 2011 Apr;34(4):982-7. doi: 10.2337/dc10-1718. Epub 2011 Feb 18.

10.

Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients.

Piarulli F, Sartore G, Ceriello A, Ragazzi E, Reitano R, Nollino L, Cosma C, Fedele D, Lapolla A.

Diabetologia. 2009 Jul;52(7):1419-25. doi: 10.1007/s00125-009-1367-y. Epub 2009 Apr 29.

PMID:
19401824
11.

Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration.

Alleyn CR, Volkening LK, Wolfson J, Rodriguez-Ventura A, Wood JR, Laffel LM.

Diabet Med. 2010 May;27(5):532-7. doi: 10.1111/j.1464-5491.2010.02983.x.

12.

Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.

Park JY, Kim HK, Chung YE, Kim SW, Hong SK, Lee KU.

Diabetes Care. 1998 Apr;21(4):530-4.

PMID:
9571337
13.

Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.

Carlsson AC, Östgren CJ, Nystrom FH, Länne T, Jennersjö P, Larsson A, Ärnlöv J.

Cardiovasc Diabetol. 2016 Feb 29;15:40. doi: 10.1186/s12933-016-0359-8.

14.

Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.

Inoue K, Matsumoto M, Akimoto K.

Diabet Med. 2008 Oct;25(10):1157-63. doi: 10.1111/j.1464-5491.2008.02572.x.

PMID:
19046193
15.

Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.

Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjörnsdottir S; Steering Committee of the Swedish National Diabetes Register.

Diabetes Res Clin Pract. 2005 Mar;67(3):258-66.

PMID:
15713359
16.

Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.

Blak BT, Smith HT, Hards M, Curtis BH, Ivanyi T.

Diabet Med. 2012 Jul;29(7):e13-20. doi: 10.1111/j.1464-5491.2012.03586.x.

PMID:
22268988
17.

Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial.

TODAY Study Group.

Diabetes Care. 2013 Jun;36(6):1735-41. doi: 10.2337/dc12-2420. Erratum in: Diabetes Care. 2013 Aug;36(8):2448.

18.

Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.

Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK.

Diabetes Care. 2000 Oct;23(10):1478-85.

19.

[Is microalbuminuria a risk factor for diabetic retinopathy?].

Romero Aroca P, Salvat Serra M, Mendez Marin I, Martinez Salcedo I.

J Fr Ophtalmol. 2003 Sep;26(7):680-4. French.

20.

Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.

Skriver MV, Støvring H, Kristensen JK, Charles M, Sandbæk A.

Diabetologia. 2012 Sep;55(9):2361-70. doi: 10.1007/s00125-012-2614-1. Epub 2012 Jun 27.

PMID:
22736395

Supplemental Content

Support Center